HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

human BT088 immunoglobulin

a human hepatitis B immunoglobulin

Also Known As:

BT088 immunoglobulin, human; zutectra

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        human BT088 immunoglobulin: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        human BT088 immunoglobulin: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        human BT088 immunoglobulin: 1

Experts

1.	Beckebaum, Susanne: 1 article (05/2011)
2.	Cicinnati, Vito: 1 article (05/2011)
3.	Klein, Christian: 1 article (05/2011)
4.	Neuhaus, Ruth: 1 article (05/2011)
5.	Pascher, Andreas: 1 article (05/2011)
6.	Paul, Andreas: 1 article (05/2011)
7.	Yahyazadeh, Ali: 1 article (05/2011)

Related Diseases

1.	Hepatitis B 05/01/2011 - "Aim of the current study was the investigation of efficacy, safety and feasibility of home-treatment of a novel human hepatitis B immunoglobulin BT088 (Zutectra) after weekly subcutaneous application in liver-transplanted patients. "
2.	Reinfection 05/01/2011 - "Weekly subcutaneous administration of BT088 (Zutectra - registered trade mark in the EU) is effective, safe and presents an easy-to-apply treatment option for combined hepatitis B virus re-infection prophylaxis in liver transplant patients (Eudra CT Number: 2005-003737-40)."

Related Drugs and Biologics

1.	Immunoglobulins (Immunoglobulin)

Related Therapies and Procedures

1.	Liver Transplantation